Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Concurrent radiation and combined bleomycin, ifosfamide, cisplatin evaluated
February 17th, 2005
According to recent research from Japan, "Combination chemotherapy consisting of bleomycin, ifosfamide, and cisplatin (BIP) is recognized as one of the most effective chemotherapies for uterine cervical cancer. However, there have been no reports that evaluate concurrent use of radiation with BIP." M. Aoki and colleagues, Tohoku University, "[evaluated] the toxicity and response of the combination of BIP concurrent with radiation in patients with squamous cell carcinoma of the uterine cervix." They wrote, "Eligibility criteria included patients who underwent radical hysterectomy (Type III hysterectomy) as a primary treatment and revealed lymph node...
Source: Women's Health Weekly (2005-02-17)
|
